Back to Search
VECIHI BATUMAN, MD
MD
Nephrology Physician
NPI: 1528159670IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
08599R(LA)
CMS Specialties
PrimaryNEPHROLOGY
Education
OTHER
Class of 1972
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Lead chelation therapy retards the decline of renal function in patients with chronic kidney disease.
PMID 17895871·Nat Clin Pract Nephrol·2007
8-other
Stranded with the patients: a nephrologist's remembrances of hurricane Katrina.
PMID 17106302·Am J Med Sci·2006
8-other
Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers.
PMID 16467889·Kidney Int·2006
8-other
Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study.
PMID 19400955·BMC Nephrol·2009
8-other
Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases.
PMID 17935800·Regul Pept·2008
6-review
Microalbuminuria as a possible marker of risk of Balkan endemic nephropathy.
PMID 19161366·Nephrology (Carlton)·2008
8-other
Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cells.
PMID 18448595·Am J Physiol Renal Physiol·2008
8-other
Estimated burden of blood lead levels 5 microg/dl in 1999-2002 and declines from 1988 to 1994.
PMID 18339369·Environ Res·2008
8-other
Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells.
PMID 17933841·Nephrol Dial Transplant·2008
8-other
Parathyroid hormone status does not influence blood and bone lead levels in dialysis patients.
PMID 18091361·Am J Med Sci·2007
8-other
Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: a case study.
PMID 17582655·Peptides·2007
5-case
Association of tibia lead and blood lead with end-stage renal disease: a pilot study of African-Americans.
PMID 17511982·Environ Res·2007
8-other
Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
PMID 17272313·Nephrol Dial Transplant·2007
8-other
Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults.
PMID 16982939·Circulation·2006
8-other
Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells.
PMID 16951196·Cancer Res·2006
8-other
Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38.
PMID 16888145·Ann N Y Acad Sci·2006
7-preclinical
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
PMID 16461961·Ann Intern Med·2006
4-observational
Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury.
PMID 16204306·Blood·2006
7-preclinical
Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys.
PMID 16217007·Arch Intern Med·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1415 TULANE AVE
NEW ORLEANS, LA 70112 - Phone
- (504) 988-2300
Quick Facts
- NPI
- 1528159670
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 54
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile